Net profit of Global Health rose 26.03% to Rs 127.38 crore in the quarter ended March 2024 as against Rs 101.07 crore during the previous quarter ended March 2023. Sales rose 14.37% to Rs 808.63 crore in the quarter ended March 2024 as against Rs 707.06 crore during the previous quarter ended March 2023.For the full year,net profit rose 46.65% to Rs 478.19 crore in the year ended March 2024 as against Rs 326.08 crore during the previous year ended March 2023. Sales rose 20.86% to Rs 3275.11 crore in the year ended March 2024 as against Rs 2709.88 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales808.63707.06 14 3275.112709.88 21 OPM %22.1823.58 -24.4023.17 - PBDT188.54171.03 10 799.83599.20 33 PBT143.09133.08 8 627.10449.29 40 NP127.38101.07 26 478.19326.08 47 Powered by Capital Market - Live News

Global Health will hold a meeting of the Board of Directors of the Company on 17 May 2024Powered by Capital Market - Live News

Global Health has allotted 20,000 equity shares under ESOP on 23 February 2024. Consequently, the paid up equity share capital of the company has increased from m Rs. 53,68,94,764/- to Rs. 53,69,34,764/. Powered by Capital Market - Live News

Global Health announced the resignation of Deepak Khanna, Financial Controller of the company with effect from 29 February 2024. Powered by Capital Market - Live News

Global Health has allotted 20,000 equity shares under ESOP on 14 February 2024. Consequent to the allotment, the paid up equity share capital has increased from Rs. 53,68,54,764/- to Rs. 53,68,94,764/-. Powered by Capital Market - Live News